{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/BBNX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T11:30:58.456Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":1489,"canonical_name":"Beta Bionics, Inc.","cik":"0001674632","uei":null,"lei":null,"duns":null,"ticker":"BBNX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":94},"count":94,"timeline":[{"ts":"2026-10-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Beta Bionics, Inc. — 2026-10-07","url_slug":"/sec/cik-0001674632/schedule-13g/0000080255-26-000609","accession_number":"0000080255-26-000609","importance":55},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-10-05","url_slug":"/sec/cik-0001674632/4/0002048497-26-000018","accession_number":"0002048497-26-000018","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-10-01","url_slug":"/sec/cik-0001674632/144/0001950047-26-009970","accession_number":"0001950047-26-009970","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-23","url_slug":"/sec/cik-0001674632/4/0002048467-26-000007","accession_number":"0002048467-26-000007","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-22","url_slug":"/sec/cik-0001674632/144/0001950047-26-009750","accession_number":"0001950047-26-009750","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4/A","title":"4/A — Beta Bionics, Inc. — 2026-09-18","url_slug":"/sec/cik-0001674632/4-a/0002048497-26-000016","accession_number":"0002048497-26-000016","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Beta Bionics, Inc. — 2026-09-17","url_slug":"/sec/cik-0001674632/8-k/0001193125-26-393322","accession_number":"0001193125-26-393322","importance":35},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-17","url_slug":"/sec/cik-0001674632/4/0002048497-26-000015","accession_number":"0002048497-26-000015","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-17","url_slug":"/sec/cik-0001674632/4/0002048500-26-000013","accession_number":"0002048500-26-000013","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"424B5","title":"424B5 — Beta Bionics, Inc. — 2026-09-17","url_slug":"/sec/cik-0001674632/424b5/0001193125-26-393320","accession_number":"0001193125-26-393320","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-16","url_slug":"/sec/cik-0001674632/144/0001950047-26-009571","accession_number":"0001950047-26-009571","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-16","url_slug":"/sec/cik-0001674632/144/0001950047-26-009580","accession_number":"0001950047-26-009580","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"424B5","title":"424B5 — Beta Bionics, Inc. — 2026-09-16","url_slug":"/sec/cik-0001674632/424b5/0001193125-26-392277","accession_number":"0001193125-26-392277","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"FWP","title":"FWP — Beta Bionics, Inc. — 2026-09-16","url_slug":"/sec/cik-0001674632/fwp/0001193125-26-392279","accession_number":"0001193125-26-392279","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Beta Bionics, Inc. — 2026-09-15","url_slug":"/sec/cik-0001674632/8-k/0001193125-26-392088","accession_number":"0001193125-26-392088","importance":35},{"ts":"2026-09-15","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-15","url_slug":"/sec/cik-0001674632/4/0002048497-26-000014","accession_number":"0002048497-26-000014","importance":30},{"ts":"2026-09-10","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-10","url_slug":"/sec/cik-0001674632/4/0002048497-26-000013","accession_number":"0002048497-26-000013","importance":30},{"ts":"2026-09-09","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-09","url_slug":"/sec/cik-0001674632/144/0001950047-26-009247","accession_number":"0001950047-26-009247","importance":30},{"ts":"2026-09-09","kind":"sec.insider.35994","reporter":"Hopman Mark","title":"Chief Commercial Officer","shares":35994,"price_per_share":18.4628,"usd_value":664550,"security_title":"Common Stock","importance":15.6645500232},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001674632/4/0002048593-26-000010","accession_number":"0002048593-26-000010","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/144/0001628280-26-060356","accession_number":"0001628280-26-060356","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/144/0002048497-26-000011","accession_number":"0002048497-26-000011","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/144/0002048500-26-000011","accession_number":"0002048500-26-000011","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/144/0002048588-26-000012","accession_number":"0002048588-26-000012","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/144/0002048593-26-000008","accession_number":"0002048593-26-000008","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/144/0002051384-26-000008","accession_number":"0002051384-26-000008","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/4/0002048497-26-000012","accession_number":"0002048497-26-000012","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/4/0002048500-26-000012","accession_number":"0002048500-26-000012","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/4/0002048588-26-000013","accession_number":"0002048588-26-000013","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/4/0002048593-26-000009","accession_number":"0002048593-26-000009","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001674632/4/0002051384-26-000009","accession_number":"0002051384-26-000009","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Beta Bionics, Inc. — 2026-08-13","url_slug":"/sec/cik-0001674632/schedule-13g-a/0000908834-26-000395","accession_number":"0000908834-26-000395","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Beta Bionics, Inc. — 2026-07-29","url_slug":"/sec/cik-0001674632/10-q/0001193125-26-323777","accession_number":"0001193125-26-323777","importance":45},{"ts":"2026-07-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Beta Bionics, Inc. — 2026-07-29","url_slug":"/sec/cik-0001674632/8-k/0001171843-26-005010","accession_number":"0001171843-26-005010","importance":35},{"ts":"2026-07-24","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Beta Bionics, Inc. — 2026-07-24","url_slug":"/sec/cik-0001674632/schedule-13g/0000919574-26-004585","accession_number":"0000919574-26-004585","importance":55},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4/A","title":"4/A — Beta Bionics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001674632/4-a/0002048588-26-000010","accession_number":"0002048588-26-000010","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001674632/4/0002048588-26-000009","accession_number":"0002048588-26-000009","importance":30},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Stephen Feider","title":"Officer","shares":4896,"usd_value":83381,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001628280-26-045940","importance":40.016676168},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":4896,"price_per_share":17.0304,"usd_value":83381,"security_title":"Common Stock","importance":35.0833808384},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":4896,"price_per_share":17.0304,"usd_value":83381,"security_title":"Common Stock","importance":35.0833808384},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-29","url_slug":"/sec/cik-0001674632/144/0001628280-26-045940","accession_number":"0001628280-26-045940","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":4896,"price_per_share":5.1,"usd_value":24970,"security_title":"Common Stock","importance":15.0249696},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":4896,"price_per_share":5.1,"usd_value":24970,"security_title":"Common Stock","importance":15.0249696},{"ts":"2026-06-26","kind":"sec.form144","reporter":"Stephen Feider","title":"Officer","shares":5104,"usd_value":87007,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001628280-26-045803","importance":40.017401356},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":5104,"price_per_share":17.0467,"usd_value":87006,"security_title":"Common Stock","importance":35.0870063568},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":5104,"price_per_share":17.0467,"usd_value":87006,"security_title":"Common Stock","importance":35.0870063568},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-26","url_slug":"/sec/cik-0001674632/144/0001628280-26-045803","accession_number":"0001628280-26-045803","importance":30},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":5104,"price_per_share":5.1,"usd_value":26030,"security_title":"Common Stock","importance":15.0260304},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":4982,"price_per_share":5.1,"usd_value":25408,"security_title":"Common Stock","importance":15.0254082},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001674632/4/0002048467-26-000005","accession_number":"0002048467-26-000005","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001674632/4/0002048497-26-000009","accession_number":"0002048497-26-000009","importance":30},{"ts":"2026-06-24","kind":"sec.form144","reporter":"CHRISTINA JONES","title":"Director","shares":1406,"usd_value":19220,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001950047-26-006469","importance":40.003844004},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Mark Hopman","title":"Officer","shares":1258,"usd_value":18827,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001628280-26-045235","importance":40.00376536},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Jones Christy","title":"","shares":1406,"price_per_share":15,"usd_value":21090,"security_title":"Common Stock","importance":35.02109},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Hopman Mark","title":"Chief Commercial Officer","shares":1258,"price_per_share":15.0083,"usd_value":18880,"security_title":"Common Stock","importance":35.0188804414},{"ts":"2026-06-24","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-24","url_slug":"/sec/cik-0001674632/144/0001628280-26-045235","accession_number":"0001628280-26-045235","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-24","url_slug":"/sec/cik-0001674632/144/0001950047-26-006469","accession_number":"0001950047-26-006469","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001674632/4/0002048467-26-000004","accession_number":"0002048467-26-000004","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001674632/4/0002048497-26-000008","accession_number":"0002048497-26-000008","importance":30},{"ts":"2026-06-04","kind":"sec.form144","reporter":"CHRISTINA JONES","title":"Director","shares":2811,"usd_value":34997,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001950047-26-005667","importance":40.00699939},{"ts":"2026-06-04","kind":"sec.form144","reporter":"Mark Hopman","title":"Officer","shares":275,"usd_value":3385,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001628280-26-040713","importance":40.00067705},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Jones Christy","title":"","shares":2811,"price_per_share":14,"usd_value":39354,"security_title":"Common Stock","importance":35.039354},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Hopman Mark","title":"Chief Commercial Officer","shares":275,"price_per_share":12.31,"usd_value":3385,"security_title":"Common Stock","importance":35.00338525},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-04","url_slug":"/sec/cik-0001674632/144/0001628280-26-040713","accession_number":"0001628280-26-040713","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-04","url_slug":"/sec/cik-0001674632/144/0001950047-26-005667","accession_number":"0001950047-26-005667","importance":30},{"ts":"2026-06-03","kind":"sec.form144","reporter":"Sean Saint","title":"Officer, Director","shares":16872,"usd_value":215793,"security_title":"Common Stock","approx_sale_date":"2026-06-02","accession_number":"0002048593-26-000005","importance":40.043158576},{"ts":"2026-06-03","kind":"sec.form144","reporter":"Stephen Feider","title":"Officer","shares":6676,"usd_value":85386,"security_title":"Common Stock","approx_sale_date":"2026-06-02","accession_number":"0002048588-26-000007","importance":40.017077208},{"ts":"2026-06-03","kind":"sec.form144","reporter":"Mark Hopman","title":"Officer","shares":5329,"usd_value":68158,"security_title":"Common Stock","approx_sale_date":"2026-06-02","accession_number":"0002048497-26-000006","importance":40.013631582},{"ts":"2026-06-03","kind":"sec.form144","reporter":"Michael R. Mensinger","title":"Officer","shares":4378,"usd_value":55995,"security_title":"Common Stock","approx_sale_date":"2026-06-02","accession_number":"0002048500-26-000008","importance":40.011198924},{"ts":"2026-06-03","kind":"sec.form144","reporter":"Steven Jon Russell","title":"Officer","shares":4222,"usd_value":53999,"security_title":"Common Stock","approx_sale_date":"2026-06-02","accession_number":"0002051384-26-000005","importance":40.010799876},{"ts":"2026-06-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/144/0002048588-26-000007","accession_number":"0002048588-26-000007","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/144/0002048593-26-000005","accession_number":"0002048593-26-000005","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/144/0002051384-26-000005","accession_number":"0002051384-26-000005","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/144/0002048497-26-000006","accession_number":"0002048497-26-000006","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/144/0002048500-26-000008","accession_number":"0002048500-26-000008","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/4/0002048497-26-000007","accession_number":"0002048497-26-000007","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/4/0002048500-26-000009","accession_number":"0002048500-26-000009","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/4/0002048588-26-000008","accession_number":"0002048588-26-000008","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/4/0002048593-26-000006","accession_number":"0002048593-26-000006","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Beta Bionics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001674632/4/0002051384-26-000006","accession_number":"0002051384-26-000006","importance":30},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Saint Sean","title":"President & CEO","shares":16872,"price_per_share":12.6071,"usd_value":212707,"security_title":"Common Stock","importance":35.2127069912},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Feider Stephen","title":"Chief Financial Officer","shares":6676,"price_per_share":12.6071,"usd_value":84165,"security_title":"Common Stock","importance":35.0841649996},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Hopman Mark","title":"Chief Commercial Officer","shares":5329,"price_per_share":12.6071,"usd_value":67183,"security_title":"Common Stock","importance":35.0671832359},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Mensinger Mike","title":"Chief Product Officer","shares":4378,"price_per_share":12.6071,"usd_value":55194,"security_title":"Common Stock","importance":35.0551938838},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Russell Steven Jon","title":"Chief Medical Officer","shares":4222,"price_per_share":12.6071,"usd_value":53227,"security_title":"Common Stock","importance":35.0532271762},{"ts":"2026-05-21","kind":"sec.form144","reporter":"ADAM LEZACK","title":"Director","shares":1998,"usd_value":20200,"security_title":"Common","approx_sale_date":"2026-05-21","accession_number":"0001950047-26-004903","importance":40.004039956},{"ts":"2026-05-21","kind":"sec.form144","reporter":"CHRISTINA JONES","title":"Director","shares":1998,"usd_value":20200,"security_title":"Common","approx_sale_date":"2026-05-21","accession_number":"0001950047-26-004904","importance":40.004039956},{"ts":"2026-05-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Beta Bionics, Inc. — 2026-05-21","url_slug":"/sec/cik-0001674632/8-k/0001171843-26-003617","accession_number":"0001171843-26-003617","importance":35},{"ts":"2026-05-21","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-05-21","url_slug":"/sec/cik-0001674632/144/0001950047-26-004903","accession_number":"0001950047-26-004903","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"144","title":"144 — Beta Bionics, Inc. — 2026-05-21","url_slug":"/sec/cik-0001674632/144/0001950047-26-004904","accession_number":"0001950047-26-004904","importance":30},{"ts":"2026-05-12","kind":"sec.13dg","reporter":"Beta Bionics, Inc.","shares":3607920,"percent_of_class":8.1,"security_title":"SCHEDULE 13G/A","accession_number":"0000908834-26-000226","excerpt":null,"importance":55},{"ts":"2026-05-12","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Farallon Capital Partners, L.P. — 2026-05-12","url_slug":"/sec/cik-0001175707/schedule-13g-a/0000908834-26-000226","accession_number":"0000908834-26-000226","importance":30},{"ts":"2026-05-08","kind":"sec.13dg","reporter":"Beta Bionics, Inc.","shares":4354501,"percent_of_class":9.8,"security_title":"SCHEDULE 13G/A","accession_number":"0001213900-26-053982","excerpt":null,"importance":55},{"ts":"2026-05-08","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Beta Bionics, Inc. — 2026-05-08","url_slug":"/sec/cik-0001674632/schedule-13g-a/0001213900-26-053982","accession_number":"0001213900-26-053982","importance":30}]}